Printed from https://fiscalreceipts.com/program/0603386A/ — data as of July 28, 2026. Every figure is citation-backed; see the page online for per-number provenance.
Biotechnology for Materials - Advanced Research
Budget Figures
FY2026 award data is a partial year — USASpending awards are reported on a rolling basis and the fiscal year does not close until September 30. why partial FY2026 data? →
- FY24
- $57.7M
- FY25
- $36.4M
- FY26
- $24.7M
● actuals (line) · ○ enacted · ◇ request — gaps are editions the program is absent from, never interpolated.
| Series | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Actuals | $0 | $0 | $51.8M | $54.8M | $57.7M | ||
| Enacted | – | $0 | $53.7M | $56.9M | $59.9M | $36.4M | |
| Request | – | – | $53.7M | $56.9M | $59.9M | $36.4M | $24.7M |
blank = series not published for this year; – = absent from that edition.
Asked vs spent: the PB2024 book requested $59.9M for FY2024; the PB2026 book reports $57.7M actually spent — $2.19M below the request.
Program Lineage
No predecessor/successor lineage was recorded for this program element — no FY-to-FY transfer into or out of this line was stated in the ingested J-books, and none was inferred from the program structure.
Description
Mission — Biotechnology Demonstration and Evaluation
This Project collaborates with Joint Service partners to mature, optimize, and demonstrate novel biotechnologies and related methods to establish a domestic resilient supply chain for defense needs. Advanced research validates and provides bio-derived, bio-functionalized, and bio-manufactured materials. This Project matures and demonstrates high-throughput screening and small-scale prototyping, enhances material performance, and exploits biotechnologies to provide drop-in replacements and materials with enhanced properties for defense applications. Areas of focus may include high-density, high-performance fuels for high-speed weapons, bio-based propellants, optical materials, and bio-derived systems that sense and respond to the presence of contaminants. Work in this Project compliments Program Element (PE) 0602386A (Biotechnology for Materials - Applied Research) / CP6 (Foundational Biotechnology Design and Dev) and PE 0604386A (Biotechnology for Materials - Dem/Val) / CQ9 (Biotechnology for Materials - Dem/Val). The cited work is consistent with the Under Secretary of Defense for Research and Engineering priority focus areas and the Army modernization strategy.
Mission — Biotechnology for Materials - Advanced Research
This Program Element (PE) matures and demonstrates novel biotechnological methods, processes, and materials to enhance military supply chain resilience. The Army is responsible for centrally managing funding for Tri-Service Biotechnology for a Resilient Supply Chain (T-BRSC) efforts. T-BRSC leverages bio-industrial manufacturing to ensure critical domestic supply chain resilience for defense needs through domestic production of raw materials and critical products. The Army supports this Tri-Service effort under this PE with collaboration among sister Services and select allied partners to support a robust pipeline for biotechnology related manufacturing. Advanced research projects optimize and rapidly demonstrate future novel biotechnologies for disruptive breakthrough capabilities. This PE provides bio-engineered and biosynthetic materials to ensure domestic sourcing of critical products in the defense supply chain. Also under this PE, efforts mature and demonstrate rapid prototyping methods for rapid testing of bio-derived materials as well as optimize models for the design and bio-security of bio-engineered materials for defense applications. This PE is coordinated with PE 0602386A (Biotechnology for Materials - Applied Research). The cited research is consistent with the Under Secretary of Defense for Research and Engineering priority focus areas and the Army Modernization Strategy. The FY 2026 request was reduced by $0.128 million for civilian personnel to optimize the workforce in compliance with Executive Order 14210, "Implementing the President's Department of Government Efficiency Workforce Optimization Initiative."
Mission — Biotechnology for Materials - Advanced Research
This Program Element (PE) matures and demonstrates novel biotechnological methods, processes, and materials to enhance military supply chain resilience. The Army is responsible for centrally managing funding for Tri-Service Biotechnology for a Resilient Supply Chain (T-BRSC) efforts. T-BRSC leverages bio-industrial manufacturing to ensure critical domestic supply chain resilience for defense needs through domestic production of raw materials and critical products. The Army supports this Tri-Service effort under this PE with collaboration among sister Services and select allied partners to support a robust pipeline for biotechnology related manufacturing. Advanced research projects optimize and rapidly demonstrate future novel biotechnologies for disruptive breakthrough capabilities. This PE provides bio-engineered and biosynthetic materials to ensure domestic sourcing of critical products in the defense supply chain. Also under this PE, efforts mature and demonstrate rapid prototyping methods for rapid testing of bio-derived materials as well as optimize models for the design and bio-security of bio-engineered materials for defense applications. This PE is coordinated with PE 0602386A (Biotechnology for Materials - Applied Research). The cited research is consistent with the Under Secretary of Defense for Research and Engineering priority focus areas and the Army Modernization Strategy. The FY 2026 request was reduced by $0.128 million for civilian personnel to optimize the workforce in compliance with Executive Order 14210, "Implementing the President's Department of Government Efficiency Workforce Optimization Initiative."
Mission — Biotechnology Demonstration and Evaluation
This Project collaborates with Joint Service partners to mature, optimize, and demonstrate novel biotechnologies and related methods to establish a domestic resilient supply chain for defense needs. Advanced research validates and provides bio-derived, bio-functionalized, and bio-manufactured materials. This Project matures and demonstrates high-throughput screening and small-scale prototyping, enhances material performance, and exploits biotechnologies to provide drop-in replacements and materials with enhanced properties for defense applications. Areas of focus may include high-density, high-performance fuels for high-speed weapons, bio-based propellants, optical materials, and bio-derived systems that sense and respond to the presence of contaminants. Work in this Project compliments Program Element (PE) 0602386A (Biotechnology for Materials - Applied Research) / CP6 (Foundational Biotechnology Design and Dev) and PE 0604386A (Biotechnology for Materials - Dem/Val) / CQ9 (Biotechnology for Materials - Dem/Val). The cited work is consistent with the Under Secretary of Defense for Research and Engineering priority focus areas and the Army modernization strategy.
Justification
Accomplishments & Planned Programs (2)
Biosynthetic Material Demonstration
This task matures and demonstrates novel and emerging biotechnologies related to bio-engineered or bio-manufactured materials to address vulnerabilities in the critical material supply chain for military needs.
Biosynthetic Material Demonstration
This task matures and demonstrates novel and emerging biotechnologies related to bio-engineered or bio-manufactured materials to address vulnerabilities in the critical material supply chain for military needs.
Budget Line Items(workbook-cited)
Exhibit R-1
| Account | Org | Type | Amount |
|---|---|---|---|
| Research, Development, Test and Evaluation, Army | A | FY24 Actuals | $57.7M |
| Research, Development, Test and Evaluation, Army | A | FY25 Enacted | $36.4M |
| Research, Development, Test and Evaluation, Army | A | FY25 Total | $36.4M |
| Research, Development, Test and Evaluation, Army | A | FY26 Disc. Request | $24.7M |
| Research, Development, Test and Evaluation, Army | A | FY26 Total | $24.7M |
Budget Details(R-2/P-40 facts)
| Project | FY24 Actuals | FY25 Total | FY26 Base | FY26 Request |
|---|---|---|---|---|
| Program Element | $57.7M | $36.4M | $24.7M | $24.7M |
| CP7: Biotechnology Demonstration and Evaluation | $57.7M | $36.4M | $24.7M | $24.7M |
No follow-the-dollar view — this program's awards haven't been crosswalked at high confidence (flows cover 17 of 1741 programs). why coverage is partial? →
Awards
No awards are linked to this program element at high confidence — the budget→award crosswalk only asserts links it can defend, and this line has none yet.
Lobbying Mentions
No Senate LDA lobbying filing in the tracked data mentions this program element by code or alias.
No research dossier for this program — dossiers cover 50 of 1741 programs, the largest fully J-book-detailed lines by FY2026 requested dollars. why no dossier here? →